Patients with a Family History of Cancer: Identification and Management

References

1. ↵
   Offit K, Brown K. Quantitating familial cancer risk: a resource for clinical oncologists. J Clin Oncol 1994; 12: 1724–36.

   OpenUrlAbstract/FREE Full Text
2. ↵
   Chew HK. Genetic evaluation of cancer: the importance of family history. Tex Med 2001; 97: 40–5.

   OpenUrl
3. ↵
   Sifri R, Gangadharappa S, Acheson LS. Identifying and testing for hereditary susceptibility to common cancers. CA Cancer J Clin 2004; 54: 309–26.

   OpenUrlCrossRefPubMed
4. ↵
   Weitzel JN. Genetic cancer risk assessment. Putting it all together. Cancer 1999; 86(11 Suppl): 2483–92.

   OpenUrl
5. ↵
   Murff HJ, Byrne D, Syngal S. Cancer risk assessment: quality and impact of the family history interview. Am J Prev Med 2004; 27: 239–45.

   OpenUrlPubMedWeb of Science
6. ↵
   Ang P, Garber JE. Genetic susceptibility for breast cancer: risk assessment and counseling. Semin Oncol 2001; 28: 419–33.

   OpenUrlPubMed
7. ↵
   Sifri RD, Wender R, Paynter N. Cancer risk assessment from family history: gaps in primary care practice. J Fam Pract 2002; 51: 856.

   OpenUrl
8. ↵
   Daly M, Farmer J, Harrop-Stein C, et al. Exploring family relationships in cancer risk counseling using the genogram. Cancer Epidemiol Biomarkers Prev 1999; 8: 393–8.

   OpenUrlAbstract/FREE Full Text
9. ↵
   Statement of the American Society of Clinical Oncology: genetic testing for cancer susceptibility, Adopted on February 20, 1996. J Clin Oncol 1996; 14: 1730–6; discussion 1737–40.

   OpenUrlAbstract/FREE Full Text
10. ↵
    National Comprehensive Cancer Network. Clinical practice guidelines in oncology [monograph on the Internet]. Jenkintown (PA): National Comprehensive Cancer Network; 2005 [cited 2005 Jan 18]. Available from: http://www.nccn.org/professionals/physician_gls/default.asp.
11. ↵
    Pharoah PD, Day NE, Duffy S, Easton DF, Ponder BA. Family history and the risk of breast cancer: a systematic review and meta-analysis. Int J Cancer 1997; 71: 800–9.

    OpenUrlCrossRefPubMedWeb of Science
12. ↵
    Colditz GA, Willett WC, Hunter DJ, et al. Family history, age, and risk of breast cancer. Prospective data from the Nurses’ Health Study. JAMA 1993; 270: 338–43.

    OpenUrlCrossRefPubMedWeb of Science
13. ↵
    Slattery ML, Kerber RA. A comprehensive evaluation of family history and breast cancer risk. The Utah Population Database. JAMA 1993; 270: 1563–8.

    OpenUrlCrossRefPubMedWeb of Science
14. ↵
    Miki Y, Swensen J, Shattuck-Eidens D, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science 1994; 266: 66–71.

    OpenUrlAbstract/FREE Full Text
15. ↵
    Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature 1995;378:789–92.
16. ↵
    Claus EB, Schildkraut JM, Thompson WD, Risch NJ. The genetic attributable risk of breast and ovarian cancer. Cancer 1996; 77: 2318–24.

    OpenUrlCrossRefPubMedWeb of Science
17. ↵
    Ford D, Easton DF, Peto J. Estimates of the gene frequency of BRCA1 and its contribution to breast and ovarian cancer incidence. Am J Hum Genet 1995; 57: 1457–62.

    OpenUrlPubMedWeb of Science
18. ↵
    Emery J, Lucassen A, Murphy M. Common hereditary cancers and implications for primary care. Lancet 2001; 358: 56–63.

    OpenUrlCrossRefPubMedWeb of Science
19. ↵
    Myriad Genetics [homepage on the Internet]. Salt Lake City (UT): Myriad Genetics [cited 2005 Feb 7]. Available from: http://www.myriad.com/index.htm.
20. ↵
    Struewing JP, Hartge P, Wacholder S, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med 1997; 336: 1401–8.

    OpenUrlCrossRefPubMedWeb of Science
21. ↵
    Lynch HT, Snyder CL, Lynch JF, Riley BD, Rubinstein WS. Hereditary breast-ovarian cancer at the bedside: role of the medical oncologist. J Clin Oncol 2003; 21: 740–53.

    OpenUrlAbstract/FREE Full Text
22. ↵
    Evans DG, Lalloo F. Risk assessment and management of high risk familial breast cancer. J Med Genet 2002; 39: 865–71.

    OpenUrlAbstract/FREE Full Text
23. ↵
    Smith RA, Saslow D, Sawyer KA, et al. American Cancer Society guidelines for breast cancer screening: update 2003. CA Cancer J Clin 2003; 53: 141–69.

    OpenUrlPubMedWeb of Science
24. ↵
    Daly M, Bryant E, Buys S, Ellis, CL. NCCN Practice Guidelines: genetic/familial high-risk assessment: breast and ovarian [monograph on the Internet]. Jenkintown (PA): National Comprehensive Cancer Network; 2004 [cited 2005 Jan 18]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/genetics_screening.pdf.
25. ↵
    Lewis S, Menon U. Screening for ovarian cancer. Expert Rev Anticancer Ther 2003; 3: 55–62.

    OpenUrlPubMed
26. ↵
    Hoskins KF, Stopfer JE, Calzone KA, et al. Assessment and counseling for women with a family history of breast cancer. A guide for clinicians. JAMA 1995; 273: 577–85.

    OpenUrlCrossRefPubMedWeb of Science
27. ↵
    Fuchs CS, Giovannucci EL, Colditz GA, Hunter DJ, Speizer FE, Willett WC. A prospective study of family history and the risk of colorectal cancer. N Engl J Med 1994; 331: 1669–74.

    OpenUrlCrossRefPubMedWeb of Science
28. ↵
    Ivanovich JL, Read TE, Ciske DJ, Kodner IJ, Whelan AJ. A practical approach to familial and hereditary colorectal cancer. Am J Med 1999; 107: 68–77.

    OpenUrlCrossRefPubMedWeb of Science
29. ↵
    Smith RA, von Eschenbach AC, Wender R, et al. American Cancer Society guidelines for the early detection of cancer: update of early detection guidelines for prostate, colorectal, and endometrial cancers. Also: update 2001–testing for early lung cancer detection. CA Cancer J Clin 2001; 51: 38–75; quiz 77–80.

    OpenUrlCrossRefPubMedWeb of Science
30. ↵
    Burt RW. Familial risk and colon cancer. Int J Cancer 1996; 69: 44–6.

    OpenUrlPubMed
31. ↵
    Levin B, Barthel J, David D, et al. Clinical practice guidelines in oncology, colorectal screening, version 1 [monograph on the Internet]. Jenkintown (PA): National Comprehensive Cancer Network; 2005 [cited 2005 Jan 18]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/colorectal_screening.pdf.
32. ↵
    Lynch HT, Smyrk T, Lynch JF. Overview of natural history, pathology, molecular genetics and management of HNPCC (Lynch syndrome). Int J Cancer 1996; 69: 38–43.

    OpenUrlCrossRefPubMedWeb of Science
33. ↵
    Lynch HT, Smyrk T, Lynch J. An update of HNPCC (Lynch syndrome). Cancer Genet Cytogenet 1997; 93: 84–99.

    OpenUrlCrossRefPubMedWeb of Science
34. ↵
    Dunlop MG, Farrington SM, Carothers AD, et al. Cancer risk associated with germline DNA mismatch repair gene mutations. Hum Mol Genet 1997; 6: 105–10.

    OpenUrlAbstract/FREE Full Text
35. ↵
    Vasen HF, Mecklin JP, Khan PM, Lynch HT. The International Collaborative Group on HNPCC. Dis Colon Rectum 1991; 34: 424–5.

    OpenUrlCrossRefPubMedWeb of Science
36. ↵
    Vasen HF, Watson P, Mecklin JP, Lynch HT. New clinical criteria for hereditary nonpolyposis colorectal cancer (HNPCC, Lynch syndrome) proposed by the International Collaborative group on HNPCC. Gastroenterology 1999; 116: 1453–6.

    OpenUrlCrossRefPubMedWeb of Science
37. ↵
    Steinberg GD, Carter BS, Beaty TH, Childs B, Walsh PC. Family history and the risk of prostate cancer. Prostate 1990; 17: 337–47.

    OpenUrlCrossRefPubMedWeb of Science
38. ↵
    Ford D, Easton DF, Bishop DT, Narod SA, Goldgar DE. Risks of cancer in BRCA1-mutation carriers. Breast Cancer Linkage Consortium. Lancet 1994; 343: 692–5.

    OpenUrlCrossRefPubMedWeb of Science
39. ↵
    Scardino P, Bahnson R, Hanks G, Trump D, et al. Clinical practice guidelines in oncology. Prostate cancer. Version 1 [monograph on the Internet] Jenkintown (PA): National Comprehensive Cancer Network; 2003 [cited 2005 Jan 18]. Available from: http://www.nccn.org/professionals/physician_gls/PDF/prostate.pdf.
40. ↵
    Prostate-specific antigen (PSA) best practice policy. American Urological Association (AUA). Oncology (Huntingt) 2000; 14: 267–72, 277–8, 280 passim.
41. ↵
    American Urological Association [homepage on the Internet]. Linthicum (MD): American Urological Association; c2005 [cited 2005 Jan 18]. Available from: http://www.urologyhealth.org/index.cfm.